A Study of Nonoxynol-9 (N-9) and HIV Infection

PHASE3CompletedINTERVENTIONAL

Enrollment

4,400

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 2001

Conditions

HIV Infections

Interventions

DRUG

Nonoxynol-9

Trial Locations (1)

Julia Welch, Research Triangle Park

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000926 - A Study of Nonoxynol-9 (N-9) and HIV Infection | Biotech Hunter | Biotech Hunter